- ►cardiobarbanza.com [PDF] DM Nathan, JB Buse, MB Davidson, E Ferrannini, RR … - Diabetologia, 2009 - Springer Page 1. CONSENSUS STATEMENT UPDATE Medical management of
hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation
and adjustment of therapy A consensus statement from the American ... Cited by 1054 - Related articles - BL Direct - All 92 versions
- ►diabetesjournals.org NN Zammitt, BM Frier - Diabetes Care, 2005 - Am Diabetes Assoc The importance of strict glycemic control to limit the risk of diabetic vascular complications is
indisputable, but many barriers obstruct its attainment. Hypoglycemia is recognized to be a major
limitation in achieving good control in type 1 diabetes (1) but has been considered to be a ... Cited by 89 - Related articles - All 6 versions
M Malone - The Annals of pharmacotherapy, 2005 - Harvey Whitney Books STUDY SELECTION AND DATA EXTRACTION : Changes in weight are generally reported as
a primary or secondary outcome of many studies. Where possible, prospective, randomized,
controlled trials were preferred; however, many studies were retrospective or open label. ... Cited by 23 - Related articles - BL Direct - All 6 versions
DM Nathan, JB Buse, MB Davidson, RJ Heine, RR … - Diabetes Care, 2006 - Am Diabetes Assoc The epidemic of type 2 diabetes in the latter part of the 20th and in the early 21st century, and
the recognition that achieving specific glycemic goals can substantially reduce morbidity, have
made the effective treatment of hyperglycemia a top priority (1–3). While the management ... Cited by 19 - BL Direct
JF Blickle - Diabetes and Metabolism, 2006 - Elsevier Glinides represent a chemically heterogeneous new class of insulinsecreting agents characterized
by a rapid onset and short duration of action. They act by closure of the ATP-dependant K
channel. Repaglinide, the only glinide available in France, has an equivalent HbA 1c ... Cited by 16 - Related articles - BL Direct - All 3 versions
M Monami, C Lamanna, N Marchionni, E … - Diabetes research and …, 2008 - Elsevier Metformin is recommended as first-line treatment in type 2 diabetic patients. Several agents can
be used as add-on treatments in metformin monotherapy failure. Most available clinical trials
on the hypoglycemic efficacy of different drugs were performed either in monotherapy or ... Cited by 12 - Related articles - All 26 versions
AK Langley, TJ Suffoletta, HR Jennings - Pharmacotherapy, 2007 - PPI As understanding of type 2 diabetes mellitus pathophysiology expands, treatments continue
to evolve and new pharmacologic targets emerge. Patients with type 2 diabetes exhibit deficiencies
of the incretin system; thus, methods for increasing insulinotropic hormones have become ... Cited by 9 - Related articles - BL Direct - All 3 versions
DF Kruger, CL Martin, CE Sadler - The Diabetes Educator, 2006 - tde.sagepub.com This review article describes the regulation of glucose homeostasis in subjects with and without
diabetes based on the emergence of new information and discusses modes of action,
attributes, and limitations of current diabetes therapies. In normal physiology, glucose ... Cited by 10 - Related articles - All 3 versions
J Li, H Tian, Q Li, N Wang, T Wu, Y Liu, Z Ni, … - Diabetes Obes …, 2007 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 8 - Related articles - All 5 versions
